Japan Orders Priority For Women In Looming Rubella Vaccine Shortage
This article was originally published in PharmAsia News
Japan health authorities, fearing a shortage of rubella vaccine come August, have dictated that women seeking motherhood be given priority at the same time it urged much of the public to get the shots.
You may also be interested in...
With a late-stage compound on its hands, MGB is currently in discussions with several biotech and pharma companies and also with venture capitalists to continue late-stage development of a novel antibiotic which could transform treatment of Clostridium difficile.
AZ and the EU are at loggerheads over supplies of the COVID-19 vaccine. On top of that, its marketing authorization will present dilemmas.
The European Medicines Agency is expected to decide soon whether Amarin’s fish oil pill, Vascepa, should win pan-EU marketing approval for reducing cardiovascular risk.